Brustkrebs: Neue Leitline zu Biomarkern; Ibrutinib/Venetoclax bei CLL
Medscape,
Im Onko-Blog dieser Woche geht es unter anderem um das Multiple Myelom. Serielle Messungen der MRD-Negativität könnten helfen…
Modern Myeloma Therapy + Sustained Minimal Residual Disease–Negative = (Functional) Cure!
Overview of attention for article published in Journal of Clinical Oncology, June 2022
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (92nd percentile)
-
High Attention Score compared to outputs of the same age and source (84th percentile)
Readers on
- mendeley
- 13 Mendeley